NF-κB as a Therapeutic Target in Inflammatory-Associated Bone Diseases

Abstract

Inflammation is a defensive mechanism for pathogen clearance and maintaining tissue homeostasis. In the skeletal system, inflammation is closely associated with many bone disorders including fractures, nonunions, periprosthetic osteolysis (bone loss around orthopedic implants), and osteoporosis. Acute inflammation is a critical step for proper bone-healing and bone-remodeling processes. On the other hand, chronic inflammation with excessive proinflammatory cytokines disrupts the balance of skeletal homeostasis involving osteoblastic (bone formation) and osteoclastic (bone resorption) activities. NF-κB is a transcriptional factor that regulates the inflammatory response and bone-remodeling processes in both bone-forming and bone-resorption cells. In vitro and in vivo evidences suggest that NF-κB is an important potential therapeutic target for inflammation-associated bone disorders by modulating inflammation and bone-remodeling process simultaneously. The challenges of NF-κB-targeting therapy in bone disorders include: (1) the complexity of canonical and noncanonical NF-κB pathways; (2) the fundamental roles of NF-κB-mediated signaling for bone regeneration at earlier phases of tissue damage and acute inflammation; and (3) the potential toxic effects on nontargeted cells such as lymphocytes. Recent developments of novel inhibitors with differential approaches to modulate NF-κB activity, and the controlled release (local) or bone-targeting drug delivery (systemic) strategies, have largely increased the translational application of NF-κB therapy in bone disorders. Taken together, temporal modulation of NF-κB pathways with the combination of recent advanced bone-targeting drug delivery techniques is a highly translational strategy to reestablish homeostasis in the skeletal system.

Gastroprotective and anti‐ulcer effects of oxymatrine against several gastric ulcer models in rats: Possible roles of antioxidant, antiinflammatory, and prosurvival mechanisms

“…NF‐κB is a master transcriptional factor in regulation of inflammatory responses. Pro‐inflammatory cytokines driven by NF‐κB are powerful signals to modulate immune cells that participate in inflammation (Lin et al, ). NF‐κB is also an essential component of ionizing radiation‐triggered signal transduction pathways that can lead to cell death or survival (Wang, Zhang, & Li, ).…”

“…Green fluorescence indicates localization of NF-κB p65, whereas DAPI shows the nucleus. Nor: normal; OXY: oxymatrine [Colour figure can be viewed at wileyonlinelibrary.com] powerful signals to modulate immune cells that participate in inflammation (Lin et al, 2017). NF-κB is also an essential component of ionizing radiation-triggered signal transduction pathways that can lead to cell death or survival (Wang, Zhang, & Li, 2002).…”

Cepharanthine: An update of its mode of action, pharmacological properties and medical applications

“…New horizons for CEP have been evoked in this review, such as a repositioning for the treatment of bone disorders in particular osteoporosis. It really makes sense because NFκB is a robust therapeutic target in inflammatory-associated bone diseases (Lin et al, 2017). CEP activates AMPK by targeting NFκB to suppress autophagy.…”

Paeonol ameliorates monosodium urate‐induced arthritis in rats through inhibiting nuclear factor‐κB‐mediated proinflammatory cytokine production

“…Nuclear factor (NF)‐κB is a critical transcription factors in inflammation response (Lin et al, ). Inflammatory stimuli including lipopolysaccharide (LPS), MSU crystals, and proinflammatory cytokines may induce NF‐κBp65 to transfer into nucleus to contribute to inflammatory gene transcription (Liu‐Bryan, Pritzker, Firestein, & Terkeltaub, ).…”